CellSeed, LA BioMed enter two-year research agreement to study primary technology in regenerative medicine LA Biomedical Research Institute at Harbor-UCLA Medical Center and CellSeed Inc http://l-e-v-i-t-r-a.com/best-drugs.html ., a Japanese biotechnology firm, have entered right into a two-year analysis agreement to review CellSeed’s proprietary primary technology in regenerative medicine, ‘Cell Sheet Engineering,’ LA BioMed President and CEO David I. Meyer, PhD, today announced.
Cell quality control system research paves method for new knowledge of neurodegenerative diseases The findings may lead to new understanding of neurodegenerative diseasesScientists from The Scripps Research Institute have solved a long-standing mystery of how cells conduct ‘quality control’ to get rid of the toxic ramifications of a certain sort of error in protein production. The findings might trigger a better understanding of a host of neurodegenerative diseases. The extensive analysis was published in an advance, on September 12 online problem of the journal Nature, 2010. ‘It is fascinating because we are coping not only with a process that’s obviously relevant for physiology and disease,’ said Scripps Research Assistant Professor Claudio Joazeiro, who led the study, ‘but also with fresh biology.’ The brand new study suggests how cells in eukaryotic organisms, like humans, sense and destroy ‘nonstop’ proteins that remain trapped in the ribosome, the proteins manufacturing facility of the cell.